About Moderna The U.S. Food and Drug Administration amended the emergency use authorizations of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months, The official News page of the Air Force Medical Service, providing the latest articles about Air Force The US Food and Drug Administration (FDA) on Wednesday authorized bivalent COVID-19 vaccines targeting the Omicron BA.4/5 subvariants developed by Pfizer-BioNTech and Moderna, asserting that the vaccines, which target the current circulating variant, will be a better match against future mutations of the SARS-CoV-2 virus. Sometimes The CDC recommends that children ages 5-11 who received Pfizer vaccine get a monovalent Pfizer booster dose at least five months after their second dose of their primary Pfizer vaccine series. Pfizer Canada and Moderna Canada each say their mRNA platforms allow for quick updates to address new variants if needed. Select CVS Pharmacy locations now offer Pfizer-BioNTech and Moderna bivalent COVID-19 booster vaccines, which offer better protection against COVID-19 caused by the omicron variant. The so-called bivalent jabs work for both the original virus that emerged in the Chinese city of Wuhan in 2019 and the BA.1 subvariant of Omicron. The UKs drug regulator said Saturday it had approved an updated Covid-19 jab by Pfizer/BioNTEch targeting the original virus and a subvariant ahead of an autumn booster drive. That submission went to Canadas federal health regulator on July 25, and authorization could be imminent. Pfizer and BioNTech are also testing several possible variant-adapted COVID-19 vaccines, including a bivalent candidate similar to Modernas. FDA oks updated Moderna, Pfizer booster shots that target omicron If approved, the booster would likely be ready by next month, according to the company. According to the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices, Pfizer is the recommended booster for ages 12 and up. Moderna also said that the new bivalent vaccine candidate has a similar safety profile to its original Spikevax vaccine, when both vaccines were administered as a second booster dose. The US Food and Drug Administration on Wednesday authorized updated Covid-19 vaccine booster shots from Moderna and Pfizer. ALLEN COUNTY, OH (WLIO) - The new Pfizer and Moderna bivalent vaccines that target the Omicron variant of COVID-19 have reached Allen County. The bivalent COVID-19 boosters from Pfizer and Moderna target the original strain of SARS-CoV-2 and the Omicron variant, which is the strain causing most current cases. According to the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices, Pfizer is the recommended booster for ages 12 and up. Everyone age 12 and older who received a primary COVID-19 vaccine series is recommended to receive a single dose of an updated bivalent booster dose; Moderna is also testing updated booster shots, including a bivalent shot that the biotechnology company said resulted in a stronger response against omicron than its original vaccine. Pfizer has said it can ship up to 15 million doses of its booster by Sept. 9. Published Sept. 2, 2022 In a statement, Moderna said the contract also includes an option to buy 234 million additional booster doses. Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus thats now the worlds most widespread. Moderna's (MRNA) bivalent COVID booster candidate exhibits a higher antibody response against all-tested COVID-19 variants, including the Omicron subvariants BA.4 and BA.5. Moderna's bivalent Covid vaccine, which targets both omicron and the original strain, provides increased protection against variants, making it a good candidate for the fall. The UK regulator last month okayed a similar bivalent vaccine by Moderna, becoming the first country to do so. The booster can only be Pfizer. Moderna believes these data collectively support updating the composition of the Company's booster to bivalent (Omicron) mRNA-1273.214 for the fall. LONDON: The UK's drug regulator said Saturday (Sep 3) it had approved an updated COVID-19 jab by Pfizer-BioNTech targeting the original virus and a subvariant ahead of an autumn booster drive. Pfizer Bivalent + Monovalent COVID-19 Vaccines. CDC backs updated COVID-19 shots from Pfizer, Moderna The Biden administration has about 170 million doses ready for a planned fall booster campaign. The first Omicron bivalent COVID-19 vaccine has been authorized: with the UKs regulatory agency giving the green light to Modernas Spikevax Bivalent Original/Omicron booster shot. The bivalent booster was generally well tolerated, with a reactogenicity and safety profile that was consistent with the prototype booster. MHRA chief executive June Raine said: "I am pleased to announce that we now have a Virginia residents are now able to schedule appointments with their healthcare providers to receive the new, free COVID-19 bivalent booster vaccinations, manufactured by Pfizer-BioNTech and Moderna. The booster can be Pfizer or Moderna. The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved the Pfizer jab as a booster for those aged 12 and over after a "careful review of the evidence". Pfizer and Moderna. Health officials are concerned about the growing prevalence of infections by omicron subvariants BA.4 and BA.5 in the U.S. and other countries. Pfizer Canada and Moderna Canada each say their mRNA platforms allow for quick updates to address new variants if needed. Moderna's bivalent booster shot covers the original SARS-CoV-2 virus, plus the BA.4 and BA.5 subvariants. Pfizer-BioNTech has also submitted its bivalent booster for regulatory assessment. The new updated boosters are targeted specifically at the BA.4 and BA.5 subvariants of the Omicron variant that initially emerged in the United States in November Spikevax bivalent Original/Omicron is indicated as a booster dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. People age 18 and older should get an updated (bivalent) booster shot at least 2 months after their second dose or last booster. The U.S. Department of Health and Human Services (HHS), in collaboration with the U.S. Department of Defense (DOD), today announced an agreement to purchase 66 million doses of Modernas bivalent COVID-19 vaccine booster candidate for potential use in the fall and winter.This contract announcement follows a recommendation by the FDA last month that Pfizer and BioNTech tested both an Omicron-specific monovalent vaccine, as well as a bivalent mix like Moderna. People can get the Moderna or Pfizer/BioNTech vaccine regardless of which brand they received in their initial shots.